OSAP vs. OSA, NMRD, DYNT, RSLS, BJDX, INVO, SINT, QNRX, GMVDF, and TNON
Should you be buying ProSomnus stock or one of its competitors? The main competitors of ProSomnus include ProSomnus (OSA), Nemaura Medical (NMRD), Dynatronics (DYNT), ReShape Lifesciences (RSLS), Bluejay Diagnostics (BJDX), INVO Bioscience (INVO), Sintx Technologies (SINT), Quoin Pharmaceuticals (QNRX), G Medical Innovations (GMVDF), and Tenon Medical (TNON). These companies are all part of the "surgical & medical instruments" industry.
ProSomnus (NASDAQ:OSAP) and ProSomnus (NASDAQ:OSA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, community ranking, risk, institutional ownership and valuation.
ProSomnus has a consensus price target of $2.33, indicating a potential upside of 2,021.21%. Given ProSomnus' higher probable upside, analysts plainly believe ProSomnus is more favorable than ProSomnus.
ProSomnus received 4 more outperform votes than ProSomnus when rated by MarketBeat users.
ProSomnus has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, ProSomnus has a beta of 0.21, meaning that its stock price is 79% less volatile than the S&P 500.
70.0% of ProSomnus shares are owned by institutional investors. Comparatively, 70.0% of ProSomnus shares are owned by institutional investors. 7.7% of ProSomnus shares are owned by insiders. Comparatively, 7.7% of ProSomnus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, ProSomnus had 1 more articles in the media than ProSomnus. MarketBeat recorded 1 mentions for ProSomnus and 0 mentions for ProSomnus. ProSomnus' average media sentiment score of 0.00 equaled ProSomnus'average media sentiment score.
Summary
ProSomnus beats ProSomnus on 6 of the 8 factors compared between the two stocks.
Get ProSomnus News Delivered to You Automatically
Sign up to receive the latest news and ratings for OSAP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OSAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ProSomnus Competitors List
Related Companies and Tools
